Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gerken

Showing results (261-270 of 307) with videos related to

Pageof 31
Sort By:
Eukaryotic Cell|September 21, 2014
Ultrastructure and composition of the Nannochloropsis gaditana cell wallMatthew J Scholz, Taylor L Weiss, Robert E Jinkerson, et al.
Zeitschrift Fur Gastroenterologie|June 1, 1997
Circulating ICAM-1 (sCD54) and LFA-3 (sCD58) in chronic hepatitis B--a longitudinal study in patients treated with interferon-alphaP A Knolle, A J Eckardt, U Protzer-Knolle, et al.
Transplantation Proceedings|December 29, 2004
Impact of combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy on renal function, cardiovascular risk factors, and graft function in liver transplant patients: preliminary results of an open prospective studyS Beckebaum, V R Cicinnati, C G Klein, et al.
European Journal of Medical Research|July 20, 2004
Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients - part III: age differencesTill Neumann, T Woiwod, A Neumann, et al.
Journal of Hepatology|December 1, 1996
Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseasesC P Strassburg, B Alex, F Zindy, et al.
Transplantation Proceedings|December 20, 2007
Efficacy of C0 and C2 monitoring in adult liver transplant recipients treated with neoral, mycophenolate mofetil, and steroidsJ Treckmann, A Paul, A Ozcelik, et al.
Journal of Hepatology|June 1, 1987
Liver cell damage caused by monoclonal antibody against an organ-specific membrane antigen in vivo and in vitroT Poralla, G Ramadori, H P Dienes, et al.
Journal of Hepatology|October 1, 1994
The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep)K Krogsgaard, N Bindslev, E Christensen, et al.
Virology|August 1, 1991
Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infectionG Gerken, D Kremsdorf, F Capel, et al.
Zeitschrift Fur Gastroenterologie|December 1, 1986
[Acute fatty liver of pregnancy. A case report of the differential diagnosis of pregnancy-associated liver diseases]G Gerken, L S Weilemann, N Börner, et al.
Pageof 31

Showing results (261-270 of 307) with videos related to

Sort By:
Pageof 31
Eukaryotic Cell|September 21, 2014
Ultrastructure and composition of the Nannochloropsis gaditana cell wallMatthew J Scholz, Taylor L Weiss, Robert E Jinkerson, et al.
Zeitschrift Fur Gastroenterologie|June 1, 1997
Circulating ICAM-1 (sCD54) and LFA-3 (sCD58) in chronic hepatitis B--a longitudinal study in patients treated with interferon-alphaP A Knolle, A J Eckardt, U Protzer-Knolle, et al.
Transplantation Proceedings|December 29, 2004
Impact of combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy on renal function, cardiovascular risk factors, and graft function in liver transplant patients: preliminary results of an open prospective studyS Beckebaum, V R Cicinnati, C G Klein, et al.
European Journal of Medical Research|July 20, 2004
Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients - part III: age differencesTill Neumann, T Woiwod, A Neumann, et al.
Journal of Hepatology|December 1, 1996
Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseasesC P Strassburg, B Alex, F Zindy, et al.
Transplantation Proceedings|December 20, 2007
Efficacy of C0 and C2 monitoring in adult liver transplant recipients treated with neoral, mycophenolate mofetil, and steroidsJ Treckmann, A Paul, A Ozcelik, et al.
Journal of Hepatology|June 1, 1987
Liver cell damage caused by monoclonal antibody against an organ-specific membrane antigen in vivo and in vitroT Poralla, G Ramadori, H P Dienes, et al.
Journal of Hepatology|October 1, 1994
The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep)K Krogsgaard, N Bindslev, E Christensen, et al.
Virology|August 1, 1991
Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infectionG Gerken, D Kremsdorf, F Capel, et al.
Zeitschrift Fur Gastroenterologie|December 1, 1986
[Acute fatty liver of pregnancy. A case report of the differential diagnosis of pregnancy-associated liver diseases]G Gerken, L S Weilemann, N Börner, et al.
Pageof 31